Mesenchymal stem cells- an excellent therapeutic agent for cancer

被引:2
|
作者
TomyTomcy, Anjilikal [1 ]
Sindhu, Edakkadath Raghavan [2 ]
机构
[1] Cent Univ Punjab, Dept Human Genet & Mol Med, Bathinda, India
[2] Malabar Canc Ctr, Dept Clin Lab Serv & Translat Res, Div Biochem, Kannur 670103, Kerala, India
关键词
antitumor activity; exosomes; mesenchymal stem cells; nanoparticles; signaling pathways; STROMAL CELLS; DRUG-DELIVERY; INDUCE APOPTOSIS; IN-VITRO; GROWTH; EXOSOMES; ANGIOGENESIS; TRAIL; AXIS;
D O I
10.1111/ajco.13969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite rapid advancement in research of diagnostics and therapeutics, cancer is the most dangerous disease-causing millions of deaths worldwide. Many of the conventional anticancer therapies can even lead to developing resistance to therapy and recurrence of cancer. To find a new, alternative treatment strategy for a variety of ailments scientists and researchers have turned their attention to cell therapies and regenerative medicine. Stem cells are now being researched for their extensive potential application in therapy for several incurable illnesses including cancer. One of the most often employed cell types for regenerative medicine is mesenchymal stem cells. Mesenchymal stem cells (MSCs) are considered a promising source of stem cells in personalized cell-based therapies. The inherent tumor tropic and immune-modulatory properties of MSCs can be used to target cancer cells. This review aims to focus on the anticancer properties of MSCs and their effect on different signaling pathways. Later on, we discuss the advantages of engineered MSCs over non-engineered MSCsin cancer therapy.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 50 条
  • [41] Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
    Hou, Weiduo
    Ye, Chenyi
    Chen, Mo
    Li, Weixu
    Gao, Xiang
    He, Rongxin
    Zheng, Qiang
    Zhang, Wei
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [42] Mesenchymal Stem Cells Derived from Umbilical Cord Blood Having Excellent Stemness Properties with Therapeutic Benefits-a New Era in Cancer Treatment
    Ray, Suman Kumar
    Mukherjee, Sukhes
    CURRENT STEM CELL RESEARCH & THERAPY, 2022, 17 (04) : 328 - 338
  • [43] Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspects
    Tesiye, Maryam Rahimi
    Kia, Zahra Abrishami
    Rajabi-Maham, Hassan
    STEM CELL RESEARCH, 2022, 63
  • [44] Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
    Jayachandran, Aparna
    Dhungel, Bijay
    Steel, Jason C.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [45] Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer
    G Kallifatidis
    B M Beckermann
    A Groth
    M Schubert
    A Apel
    A Khamidjanov
    E Ryschich
    T Wenger
    W Wagner
    A Diehlmann
    R Saffrich
    U Krause
    V Eckstein
    J Mattern
    M Chai
    G Schütz
    A D Ho
    M M Gebhard
    M W Büchler
    H Friess
    P Büchler
    I Herr
    Cancer Gene Therapy, 2008, 15 : 231 - 240
  • [46] Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
    Aparna Jayachandran
    Bijay Dhungel
    Jason C. Steel
    Journal of Hematology & Oncology, 9
  • [47] Mesenchymal Stem Cells and Cancer: Tumor-Specific Delivery Vehicles or Therapeutic Targets?
    Dwyer, R. M.
    Kerin, M. J.
    HUMAN GENE THERAPY, 2010, 21 (11) : 1506 - 1512
  • [48] Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
    Sasportas, Laura S.
    Kasmieh, Randa
    Wakimoto, Hiroaki
    Hingtgen, Shawn
    van de Water, Jeroen A. J. M.
    Mohapatra, Gayatry
    Figueiredo, Jose Luiz
    Martuza, Robert L.
    Weissleder, Ralph
    Shah, Khalid
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) : 4822 - 4827
  • [49] Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer
    Kallifatidis, G.
    Beckermann, B. M.
    Groth, A.
    Schubert, M.
    Apel, A.
    Khamidjanov, A.
    Ryschich, E.
    Wenger, T.
    Wagner, W.
    Diehlmann, A.
    Saffrich, R.
    Krause, U.
    Eckstein, V.
    Mattern, J.
    Chai, M.
    Schuetz, G.
    Ho, A. D.
    Gebhard, M. M.
    Buechler, M. W.
    Friess, H.
    Buechler, P.
    Herr, I.
    CANCER GENE THERAPY, 2008, 15 (04) : 231 - 240
  • [50] Mesenchymal stem cells and their potential therapeutic benefits and challenges in the treatment and pathogenesis of gastric cancer
    Mohamed, Asma 'a H.
    Shafie, Alaa
    Al Abdulmonem, Waleed
    Alzahrani, Hassan Swed
    Ashour, Amal Adnan
    Hjazi, Ahmed
    Jamal, Azfar
    Aldreiwish, Allolo D.
    Kamal, Mohammad Azhar
    Ahmad, Fuzail
    Khan, Nazia
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 260